Health Enhancement Product (OTC BB: HEPI) Management Interview

This interview has expired.
Click here to find stocks, with exciting stories, and management committed to maximizing shareholder value.

Special deals for our readers
Are you qualified for the Visa Black Card?
The World’s Most Prestigious and Versatile Credit Card. Apply Now!

Be a more profitable investor:
What’s Jim Cramer trading in his personal portfolio? Click here

Get an Equifax 3-in-1 Credit Report Now!

Why are you still paying too much with Schwab, and and E-trade?? Step up to the #1 discount broker: TradeKing.
Find out why TradeKing.com was ranked #1 Discount Broker by SmartMoney Magazine two years running! (August 2006 & 2007).

Invest Smarter! Get 4 Bonus Weeks of Investor’s Business Daily Digital Edition!

LifeLock is the only Identity Theft Prevention Solution backed by a one-million dollar guarantee!Click here to get a 10% discount.

Get FICO Score Watch Now!

Free Quicken Online automatically categorizes your expenses.

Click here to get access to powerful investing tools only available at Investor’s Business Daily.

Get a free look at Jim Cramer’s Action Alerts PLUS portfolio. Click here

Health Enhancement Product
(OTC BB: HEPI)
John Gorman, Director of Sales

Health Enhancement Products, Inc. (HEPI) is focused on producing only products derived from natural ingredients. The Company’s primary offering is the enzyme-based, all natural dietary supplement known as ProAlgaZyme (PAZ). The Company operates through its wholly owned subsidiaries, Health Enhancement Corporation (HEC) and HEPI Pharmaceuticals, Inc. (HEPI Pharma). HEPI Pharma develops potential pharmaceutical applications for the HEPI’s PAZ product. ProAlgaZyme is a naturally-generated liquid product derived from a natural plant culture grown in purified water with the Company’s own feeding.

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.